This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Therapeutic Drug Monitoring Markets

Table 2.3: Key Attributes of Therapeutic Drug Monitoring 17

Table 2.4: Process of Therapeutic Drug Monitoring 26

Table 2.5: Information required to correctly interpret TDM concentration 27

Table 3.1: Monitored Therapeutic Drugs by Category and Indications 29

Table 3.2: Commonly Monitored Drugs 30

Table 3.3: Common Antiepileptic Drugs that undergo Therapeutic Drug Monitoring

30

Table 3.4: Proposed Therapeutic Range for newer Antiepileptics 31

Table 3.5: Antiepileptic Drug Monitoring Indications 31

Table 3.6: Application of Therapeutic Ranges for Antiepileptic Therapies 31

Table 3.7: Classification and examples of Antiarrhythmic Agents 33

Table 3.8 Antiarrhythmic Drugs, Indication and Therapeutic Range 33

Table 3.9: Commonly Prescribed Antiarrhythmic Drugs 33

Table 3.10: Recommended Collection Logistics and Sampling times for

Antiarrhythmic Therapeutic

Monitoring 34

Table 3.11: Analytical Issues in Monitoring Cardiac Drugs 34

Table 3.12: Drug Interactions Observed for Cardiac Drugs 34

Table 3.13: Short Term Side Effects of Lithium 36

Table 3.14: Long Term Side Effects of Lithium 36

Table 3.15: Classification of Antineoplastic agents 37

Table 3.16: General Toxicities of Antineoplastic Drugs 38

Table 3.17: Toxic effects of Methotrexate 38

Table 3.18: Therapeutic Range of Common Bronchodilators 39

Table 3.19: Toxic effects of Theophylline 39

Table 3.20: Toxic effects of Caffeine 39

Table 3.21: Common Antibiotics and their Therapeutic Ranges used in Therapeutic

Drug Monitoring 40

Table 3.22: Types of Immunosuppressant Therapeutics 41

Table 3.23: Non-steady State Kinetics of Immunosuppressant's in Therapeutic Drug

Monitoring 42

Table 3.24: Common Immunosuppressant Agents in Therapeutic Drug Monitoring 42

Table 3.25: European and U.S. Guidelines for Therapeutic Drug Monitoring of

Antiretroviral Drugs 44

Table 3.26: Antiretroviral Therapy in Children in Low- and Middle-Income

Countries 45

Table 3.27: Antiretroviral Therapy Coverage in Low- and Middle-Income Countries

45

Table 3.28: Suggested Minimum Trough Plasma Concentrations for Individuals with

Wild-Type HIV 46

Table 3.29: Guidelines for Therapeutic Management of Antiretroviral Drugs 47

4 of 10

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs